Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis

Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

Relationship Between Rates of ElevatedLiver Enzymes and % LDL-C Reduction


Relationship Between Rates ofRhabdomyolysis and % LDL-C Reduction


Rate of Elevated LiverEnzymes by Statin Dose Category


Rate of Elevated LiverEnzymes by Lovastatin Dose Category


Rate of Elevated LiverEnzymes by Simvastatin Dose Category


Rate of Elevated LiverEnzymes by Atorvastatin Dose Category


Characteristics of Large Prospective Randomized Controlled Statin Trials in Which Incident Cancer Rates Were

Reported, and Used for the Present Analysis


Relationship Between Rates of Newly Diagnosed Cancer per 100,000 Person-Years and % LDL-C

Reduction


Relationship Between Rates of Newly Diagnosed Cancer per 100,000 Person-Years and Absolute LDL-C

Reduct


Relationship Between Rates of Newly Diagnosed Cancer per 100,000 Person-Years and Achieved LDL-C

Level


Rate of Newly DiagnosedCancer by Statin Dose Category


References


Alawi A. Alsheikh-Ali, et al. JACC 2007;50:409-18

Documents

ldlc reductionalawi

rate of elevated liverenzymes

lovastatin dose categoryalawi

simvastatin dose categoryalawi

ldlc levelalawi

incident cancer rates

diagnosed cancer

rates ofrhabdomyolysis